Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum
- 1 February 1997
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 931-932
- https://doi.org/10.1016/s0041-1345(96)00250-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in manResearch in Immunology, 1996
- EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX VIVO XENOGENEIC PERFUSION MODEL1,2Transplantation, 1996
- A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejectionGenes to Cells, 1996
- TRANSGENIC EXPRESSION OF HUMAN COMPLEMENT REGULATORY PROTEINS IN MICE RESULTS IN DIMINISHED COMPLEMENT DEPOSITION DURING ORGAN XENOPERFUSIONTransplantation, 1995
- Transplantation of discordant xenografts: a review of progressImmunology Today, 1990
- CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.The Journal of Experimental Medicine, 1989